Morphological aspects and therapeutic options in melanoma: a narrative review of the past decade

Vol. 64 No. 2, 2023


Andreea Catalina Tinca, Andrada Raicea, Andreea Raluca Szoke, Iuliu Gabriel Cocuz, Mihaela Cornelia Sincu, Raluca Niculescu, Adrian Horatiu Sabau, Maria Catalina Popelea, Radu Florin Fruntelata, Ovidiu Simion Cotoi

Melanoma is a malignant cancer of the skin, the incidence of which has been increasing year by year. This neoplasm has high aggressivity as well as the potential for invasion and metastases. Multiple factors related to the proliferation of this type of tumor have been identified, such as exposure to ultraviolet (UV) radiation and specific genetic backgrounds. From a histological and cytological point of view, the most common cells that are found in melanoma are epithelioid or spindle cells. To confirm the diagnosis and the melanocytic origin of the tumor, specific and sensitive markers are used. Also, observation of the behavior of this cancer, including its proliferative properties, has led to the development of multiple therapies, each of which is characteristic of the pathological stage at the time of diagnosis. While surgery is the most important therapeutic and curative option in cases of melanoma in situ, chemotherapy has been the main treatment for advanced stages of melanoma for many years. However, recently, targeted therapy and immunotherapy have changed the approach to treatment. At present, multiple studies are attempting to obtain further data about the tumor microenvironment and investigating how targeting particular molecules can change the prognosis of patients.

Corresponding author: Andrada Raicea, MD; e-mail:

DOI: 10.47162/RJME.64.2.02 Download PDF
Download cover
Download contents

Journal archive